📄 中文摘要
随着生物技术与人工智能的交汇，一家由亿万富翁投资的初创公司致力于改变药物测试的方法。该公司通过创造“器官袋”——微型实验室培养的器官，设想了一个动物实验可能变得过时的未来。这一创新不仅旨在提高药物开发的伦理性，还希望提升其有效性。传统的药物开发依赖于动物实验，尽管这一做法已久，但引发了关于动物待遇和结果有效性的伦理担忧。研究表明，动物模型有时无法准确反映人类的生理反应，因此，开发更具人道和科学依据的替代方案显得尤为重要。
亿万富翁支持的初创公司希望培育“器官袋”以替代动物实验
📄 English Summary
A Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal Testing
A startup backed by billionaire investors is aiming to revolutionize drug testing through the development of 'organ sacks'—miniature lab-grown organs. This innovative approach seeks to eliminate the reliance on animal testing, addressing ethical concerns and enhancing the efficacy of drug development. Traditionally, drug development has depended heavily on animal testing, which raises significant ethical issues regarding animal welfare and the validity of results. Research indicates that animal models can sometimes fail to accurately represent human physiological responses, highlighting the urgent need for more humane and scientifically sound alternatives in the field of drug testing.